Circulating fibrocytes and pulmonary arterial hypertension

European Respiratory Journal

Volumn 39, Issue 1, 2012, Pages 210-212

  Gambaryan, N ^a,b,c   Cohen Kaminsky, S ^a,b,c   Montani, D ^a,b,c   Girerd, B ^a,b,c   Huertas, A ^a,b,c   Seferian, A ^a,b,c   Humbert, M ^a,b,c   Perros, F ^a,b,c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID P COMPONENT; CD11B ANTIGEN; CD34 ANTIGEN; COLLAGEN TYPE 1; CYTOKINE; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; VIMENTIN;

BONE MARROW CELL; CELL ACTIVATION; CELL ACTIVITY; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELLULAR DISTRIBUTION; DISEASE ACTIVITY; DISEASE COURSE; HUMAN; IN VITRO STUDY; LETTER; LUNG FIBROBLAST; MONOCYTE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PULMONARY HYPERTENSION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; EPOPROSTENOL; FEMALE; FIBROBLASTS; HUMANS; HYPERTENSION, PULMONARY; LEUKOCYTES, MONONUCLEAR; MALE;

EID: 84855368771     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00039811     Document Type: Letter

References (10)

1. Stenmark KR, Frid MG, Yeager ME. Fibrocytes: potential new therapeutic targets for pulmonary hypertension? Eur Respir J 2010; 36: 1232-1235.
2. Nikam VS, Schermuly RT, Dumitrascu R, et al. Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension. Eur Respir J 2010; 36: 1302-1314.
3. Montani D, Perros F, Gambaryan N, et al. C-kit positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2011; 184: 116-123.
4. Gambaryan N, Perros F, Montani D, et al. Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension. Eur Respir J 2011; 37: 1392-1399.
5. Frid MG, Brunetti JA, Burke DL, et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol 2006; 168: 659-669. (Pubitemid 43271163)
6. Bucala R, Spiegel L, Chesney J, et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994; 1: 71-81.
7. Strieter RM, Keeley EC, Hughes MA, et al. The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J Leukoc Biol 2009; 86: 1111-1118.
8. Pilling D, Vakil V, Gomer RH. Improved serum-free culture conditions for the differentiation of human and murine fibrocytes. J Immunol Methods 2009; 351: 62-70.
9. Heeschen C, Lehmann R, Honold J, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004; 109: 1615-1622. (Pubitemid 38451717)
10. Hogg N, Leitinger B. Shape and shift changes related to the function of leukocyte integrins LFA-1 and Mac-1. J Leukoc Biol 2001; 69: 893-898. (Pubitemid 32577889)